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Zebrafish neurofibromatosis type 1 genes have
redundant functions in tumorigenesis and embryonic
development
Jimann Shin1,*,‡, Arun Padmanabhan2,‡, Eric D. de Groh2,‡, Jeong-Soo Lee1,§, Sam Haidar3, Suzanne Dahlberg1,
Feng Guo1, Shuning He1, Marc A. Wolman2, Michael Granato2, Nathan D. Lawson4, Scot A. Wolfe4, Seok-Hyung Kim5,
Lilianna Solnica-Krezel6, John P. Kanki1, Keith L. Ligon3, Jonathan A. Epstein2,¶ and A. Thomas Look1,¶
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SUMMARY
Neurofibromatosis type 1 (NF1) is a common, dominantly inherited genetic disorder that results from mutations in the neurofibromin 1 (NF1) gene.
Affected individuals demonstrate abnormalities in neural-crest-derived tissues that include hyperpigmented skin lesions and benign peripheral
nerve sheath tumors. NF1 patients also have a predisposition to malignancies including juvenile myelomonocytic leukemia (JMML), optic glioma,
glioblastoma, schwannoma and malignant peripheral nerve sheath tumors (MPNSTs). In an effort to better define the molecular and cellular
determinants of NF1 disease pathogenesis in vivo, we employed targeted mutagenesis strategies to generate zebrafish harboring stable germline
mutations in nf1a and nf1b, orthologues of NF1. Animals homozygous for loss-of-function alleles of nf1a or nf1b alone are phenotypically normal
and viable. Homozygous loss of both alleles in combination generates larval phenotypes that resemble aspects of the human disease and results
in larval lethality between 7 and 10 days post fertilization. nf1-null larvae demonstrate significant central and peripheral nervous system defects.
These include aberrant proliferation and differentiation of oligodendrocyte progenitor cells (OPCs), dysmorphic myelin sheaths and hyperplasia of
Schwann cells. Loss of nf1 contributes to tumorigenesis as demonstrated by an accelerated onset and increased penetrance of high-grade gliomas
and MPNSTs in adult nf1a+/–; nf1b–/–; p53e7/e7 animals. nf1-null larvae also demonstrate significant motor and learning defects. Importantly, we
identify and quantitatively analyze a novel melanophore phenotype in nf1-null larvae, providing the first animal model of the pathognomonic
pigmentation lesions of NF1. Together, these findings support a role for nf1a and nf1b as potent tumor suppressor genes that also function in the
development of both central and peripheral glial cells as well as melanophores in zebrafish.

INTRODUCTION
Type 1 neurofibromatosis (NF1) is an autosomal dominant
inherited genetic disorder characterized by pigmented birthmarks
known as café-au-lait spots, cutaneous and plexiform
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neurofibromas arising in the glial cells of the peripheral nervous
system (PNS), optic pathway gliomas, cardiovascular abnormalities
and learning defects (Williams et al., 2009). The disease results from
mutations in the NF1 gene, encoding the large protein
neurofibromin, which contains a GTPase-activating protein-related
domain (GRD) capable of inactivating the RAS proto-oncogene
(Cawthon et al., 1990; Viskochil et al., 1990; Wallace et al., 1990).
Thus, NF1 loss results in aberrant activation of Ras signaling, which
may predispose NF1 patients to a variety of cancers (Cichowski
and Jacks, 2001). Heterozygous Nf1 mutant mice develop
pheochromocytoma and myeloid leukemia, whereas the
conditional loss of Nf1 in a p53-deficient background results in
highly penetrant malignant astrocytoma formation (Jacks et al.,
1994; Zhu et al., 2005a; Powers et al., 2007). Furthermore, two recent
reports have identified NF1 mutations in approximately 15-23% of
human glioblastoma patients (Parsons et al., 2008; The Cancer
Genome Atlas Research Network, 2008). Although these studies
demonstrate a strong link between NF1 function and high-grade
glioma, the crucial signaling pathways governing the development
of tumorigenesis remain to be elucidated. An animal model
facilitating the rapid interrogation of epistatic and functional
relationships within signaling pathways would serve as a valuable
tool for probing the pathology underlying NF1-induced cell
transformation.
We recently developed a zebrafish model of NF1 deficiency using
antisense morpholino oligonucleotides to produce transient gene
knockdown (Padmanabhan et al., 2009; Lee et al., 2010). Two
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zebrafish orthologues were identified that are highly homologous
to human NF1 at the amino acid level, sharing approximately 84%
identity, including 91-93% identity within the GRD. Both genes
maintain syntenic relationships with human NF1 on chromosome
17q11.2 and are probably the result of the well-described genomic
duplication event that occurred early in the evolution of teleosts
(Amores et al., 1998). In our previous work with nf1 morphants,
we observed defects in both cardiovascular and nervous system
development. However, due to the transient nature of morpholino
gene knockdown, the analysis of nf1-deficient phenotypes beyond
the first 3 days of life was not possible.
We report here the generation of stable mutant nf1 zebrafish
lines, using both zinc finger nuclease (ZFN) and targeting induced
local lesions in genomes (TILLING) strategies, and the detailed
phenotypic analysis of this new animal model of human NF1. We
have successfully generated several independent null alleles of nf1a
and nf1b. Mutant larvae carrying at least one wild-type nf1a or
nf1b allele are viable, fertile and show no obvious phenotypes during
early development. By contrast, nf1a–/–; nf1b–/– larvae exhibit overt
pigmentation defects as early as 6 days post fertilization (dpf ) and
do not survive beyond 10 dpf. Beginning at 4 dpf, nf1a–/–; nf1b–/–
larvae exhibit hyperplasia of oligodendrocyte progenitor cells
(OPCs) and Schwann cells, as well as melanophore hypoplasia.
Defects resulting from the loss of nf1 in pigment cell and glial cell
lineages mirror those often observed in the tissues of NF1 patients.
In a p53 mutant background (p53e7/e7), nf1a+/–; nf1b–/– fish develop
high-grade gliomas and malignant peripheral nerve sheath tumors
(MPNSTs), demonstrating a tumor-suppressor function for the
zebrafish nf1 orthologues. Therefore, we have developed and
characterized a heritable zebrafish model of NF1 that exhibits
clinical hallmarks of the disorder, including nervous system defects
and increased susceptibility to tumorigenesis. Furthermore, nf1
mutant zebrafish represent the first vertebrate model of the
pathognomonic pigmentation lesions associated with NF1.
RESULTS
Generation of zebrafish nf1a and nf1b mutants
We previously identified two zebrafish orthologues of human NF1,
nf1a and nf1b, and described the phenotypes that result from their
loss of function during early development induced by antisense
morpholino oligonucleotides (Padmanabhan et al., 2009; Lee et al.,
2010). Although this technology readily permits transient
knockdown of gene expression, its efficacy is limited to only the
first few days of life. In an effort to gain a better understanding of
the roles of nf1a and nf1b during development, as well as in cancer
predisposition, we employed multiple approaches to develop stable
lines of zebrafish harboring germline mutations in each of these
genes. Using a modular approach (Zhu et al., 2011), zinc finger
nucleases (ZFNs) were engineered with binding specificities directed
to exon 26 of nf1a and exon 17 of nf1b (Fig. 1A,B). Paired ZFN
mRNAs were injected into zebrafish embryos and independent
target-specific mutant alleles for nf1a (nf1a⌬5 and nf1a⌬8) and nf1b
(nf1b+10 and nf1b⌬55) were identified in the F1 generation (Fig. 1C;
supplementary material Fig. S1A-D). Each of these mutations
included a deletion and/or insertion within a coding exon that
resulted in a frameshift, introducing premature stop codons that
would be expected to truncate the neurofibromin protein upstream
of the GRD (Fig. 1D,E). In a separate effort, we screened a library
882
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of N-ethyl-N-nitrosourea (ENU)-mutagenized zebrafish by targeting
induced local lesions in genomes (TILLING) (Wienholds et al., 2002)
and identified a single founder harboring a nonsense mutation in
exon 29 of nf1a (nf1aL1247X) (Fig. 1C; supplementary material Fig.
S1E-G). To confirm that the targeted alleles disrupted production
of full-length protein, we performed western blots using an antibody
that should recognize both nf1a and nf1b with extracts prepared
from 3 dpf wild-type, nf1a⌬5/⌬5; nf1b+/+, nf1a+/+; nf1b+10/+10 and
nf1a⌬5/⌬5; nf1b+10/+10 larvae (Fig. 1F). We observed a complete loss
of Nf1 signal in the double-homozygous null extracts. We detected
only low levels of protein expression in nf1a⌬5/⌬5; nf1b+/+ mutant
extracts as compared with wild-type or nf1a+/+; nf1b+10/+10 mutant
extracts, which might reflect differences in expression levels of the
two orthologues at 3 dpf. However, we cannot rule out the possibility
that the neurofibromin antibody we used recognizes the two
proteins with different affinities. We generated separate zebrafish
lines with distinct null alleles of both nf1a and nf1b to provide
evidence that the observed phenotypes were in fact due to nf1 loss
and did not involve any spurious passenger mutations specific to
the isolation of any individual nf1 mutant line (supplementary
material Fig. S2). Because our data indicate that these various null
alleles are equivalent, we refer to them without individual allelic
designations henceforth (nf1a–/– and nf1b–/–).
Mutants carrying at least one wild-type allele of either nf1a or
nf1b are viable and fertile. However, when crossing parental
genotypes that would be expected to yield nf1a–/–; nf1b–/– progeny,
none were observed in the adult population. To investigate this
further, we performed quantitative survival studies. At 7 dpf,
nf1a–/–; nf1b–/– larvae began to die, with none surviving beyond
10 dpf, although 100% of wild-type larvae survived to 10 dpf (Fig.
1G). Furthermore, 100% survival at 10 dpf was also observed in
nf1a–/–; nf1b+/+ (n26), nf1a+/+; nf1b–/– (n22), nf1a–/–; nf1b+/–
(n28) and nf1a+/–; nf1b–/– (n24) larvae. The swim bladders of
nf1a–/–; nf1b–/– larvae were frequently observed to be underinflated.
However, nf1a–/–; nf1b–/– larvae maintained the ability to both
consume and transit live paramecia, suggesting that premature
death was not the result of starvation (supplementary material Fig.
S3). Additionally, an incompletely penetrant valvular insufficiency
phenotype was appreciated in nf1a–/–; nf1b–/– larvae, as well as in
those harboring only a single wild-type nf1 allele (nf1a+/–; nf1b–/–
and nf1a–/–; nf1b+/–) (supplementary material Movies 1-3).
OPC and Schwann cell hyperplasia in nf1a–/–; nf1b–/– larvae
We previously described OPC hyperplasia after nf1a and nf1b
morpholino knockdown in the context of a homozygous p53
mutant background (Lee et al., 2010). To examine nf1a and nf1b
function in OPCs and other tissues beyond the first few days of
life, we crossed several cell-type-specific zebrafish reporter lines
into nf1a/nf1b mutant backgrounds. At 2 dpf, olig2 expression
appeared normal in Tg(olig2:GFP); nf1a–/–; nf1b–/– embryos, as
assessed by both whole-mount in situ hybridization analysis of
endogenous olig2 mRNA expression and GFP expression
(supplementary material Fig. S4A-D). We also evaluated nf1 loss
in Tg(sox10:GFP) embryos. This transgene drives GFP expression
in specified ventral spinal cord OPCs, but not the neighboring
motoneurons that arise from a common progenitor cell, as well as
in Schwann cells of the posterior lateral line nerve (PLLn). At 2
dpf, similar numbers of sox10:GFP-positive OPCs were detected
dmm.biologists.org
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which innervate skin mechanosensory neuromast cells
(supplementary material Fig. S4G,H).
However, nf1a–/–; nf1b–/– larvae exhibited increased numbers of
OPCs at 4 dpf compared with controls, as evidenced by an excess
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in the dorsal and ventral spinal cord of wild-type and nf1a–/–;
nf1b–/– embryos (supplementary material Fig. S4E,F). Examination
of nf1-null PNS Schwann cells at 2 dpf showed no effect on the
number of sox10:GFP-expressing cells associated with the PLLn,

RESEARCH ARTICLE

Fig. 1. ZFN and TILLING strategies generate null alleles of zebrafish nf1a and nf1b. (A,B)Scheme of site targeted for ZFN-mediated cleavage in exon 26 of
nf1a and exon 17 of nf1b. (C)Alignments of nucleotide sequences from wild-type and mutant nf1a and nf1b alleles. ZFN target sites appear in red. Yellow bases
represent insertions that arise from repair of ZFN-induced mutagenic lesions. Black bases correspond to the mutated codon in the nf1aL1247X allele generated by
a TILLING strategy, with the mutated base appearing in blue. (D)ZFN-induced mutagenic lesions in nf1a and nf1b produce frameshift mutations that lead to
truncated protein products following short regions of altered translation, which are indicated in green. The nonsense mutation in the nf1aL1247X allele generated
by a TILLING strategy also appears in green. (E)The truncated protein products predicted by the ZFN- and TILLING-induced mutant nf1a/nf1b alleles all harbor
complete or partial loss of the neurofibromin GAP-related domain (GRD). (F)Western blot analysis for neurofibromin in protein lysates from 3 dpf wild-type,
nf1a5/5; nf1b+/+, nf1a+/+; nf1b+10/+10 and nf1a5/5; nf1b+10/+10 zebrafish larvae (100g each) or 293T cells (25 g) demonstrates absence of Nf1 protein in nf1a–/–;
nf1b–/– larvae. Equal loading was confirmed by stripping the membrane and reprobing for -tubulin. (G)Kaplan-Meier survival analysis demonstrates that 100%
of nf1a–/–; nf1b–/– larvae (n22) die by 10 dpf as compared with 0% of wild-type larvae (n27).
Disease Models & Mechanisms
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of dorsally migrated olig2:GFP-positive OPCs (Fig. 2A,B) along with
increased numbers of both dorsally and ventrally positioned
sox10:GFP-positive OPCs (Fig. 2C,D), consistent with our analyses
of nf1 morphants at 3 dpf (Lee et al., 2010). In addition, we observed
an increase in sox10:GFP-positive Schwann cells associated with
the PLLn (Fig. 2E,F). This increase in PLLn Schwann cell number
was not associated with altered proliferation of these cells
(supplementary material Fig. S5A-F). To assess the roles of nf1a
and nf1b in the developing radial glial cells of the spinal cord,
nf1a/nf1b mutants were crossed into the Tg(gfap:GFP) line, which
expresses GFP from the glial fibrillary acidic protein (gfap)
promoter. At 4 dpf, nf1a–/–; nf1b–/– larvae harboring a gfap:GFP
transgene demonstrated no readily discernible differences in
gfap:GFP-positive spinal cord radial glial cells as compared with
wild-type larvae (supplementary material Fig. S4I,J). However, gfap
expression in the extensive processes of radial glial cells precludes
precise quantification and might obscure subtle differences.
To determine whether neuronal numbers increased in concert
with OPCs in nf1a/nf1b mutant larvae, we used anti-HuC/D and
anti-SOX10 antibodies (see Methods) to discriminate between
olig2:GFP-positive neurons and OPCs, respectively. No difference
between the number of olig2:GFP-positive and HuC/D-positive
neurons was appreciable in 4 dpf spinal cord sections from wildtype and nf1a–/–; nf1b–/– larvae (Fig. 2G,H, green and magenta; Fig.
2K). However, the numbers of olig2:GFP-positive and Sox10positive OPCs (Fig. 2G,H, arrowheads; Fig. 2L) and PLLn Schwann
cells (Fig. 2I,J,M) were significantly increased at 4 dpf in nf1a–/–;
nf1b–/– larvae relative to wild-type controls. OPC cell numbers
continued to increase in nf1a–/–; nf1b–/– larvae at 8 dpf, as reflected
by increased numbers of dorsally localizing olig2:GFP-positive
OPCs as well as both dorsally and ventrally localizing sox10:GFPpositive OPCs (supplementary material Fig. S4M-P). Increased
numbers of sox10:GFP-expressing PLLn Schwann cells were also
evident in nf1a–/–; nf1b–/– larvae at 8 dpf (supplementary material
Fig. S4Q,R). Thus, loss of nf1a and nf1b does not affect the
specification of OPCs at 2 dpf, but instead promotes the progressive
expansion of OPCs without a concomitant increase in neuronal
cell numbers. Furthermore, nf1a/nf1b loss triggers Schwann cell
hyperplasia beginning at 4 dpf.
Immunohistochemical analysis using the Zrf1 antibody, which
labels Gfap in zebrafish, showed coexpression with GFP expressed
from the gfap:GFP transgene and revealed a similar pattern of
expression in wild-type and nf1a–/–; nf1b–/– larvae at 4 dpf
(supplementary material Fig. S6A,B). Zebrafish radial glial cells also
express
brain
lipid-binding
protein
(Blbp),
and
immunohistochemical analysis of wild-type and nf1a–/–; nf1b–/–
spinal cords with an anti-BLBP antibody at 4 dpf revealed an
obvious decrease in Blbp expression in the gfap:GFP-positive radial
glia of nf1a–/–; nf1b–/– larvae (supplementary material Fig. S6C,D).
These results suggest that although gfap:GFP-positive radial glial
cells in nf1a–/–; nf1b–/– larvae appear normal in number, they fail
to express appropriate levels of Blbp indicating a defect in
gliogenesis. An additional abnormality of gliogenesis was observed
at 8 dpf as a disruption in the regular segmental pattern of glial
process outgrowth in Tg(gfap:GFP); nf1a–/–; nf1b–/– larvae
(supplementary material Fig. S4K,L).
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Fig. 2. Loss of nf1a and nf1b causes hyperplasia of OPCs and Schwann cells.
(A,B)Confocal images of spinal cords in nf1a–/–; nf1b–/–; Tg(olig2:GFP) larvae (B)
demonstrate increased numbers of dorsally migrating (white brackets)
olig2:GFP-positive OPCs as compared with wild-type; Tg(olig2:GFP) larvae (A) at 4
dpf. (C,D)Confocal images of spinal cord in nf1a–/–; nf1b–/–; Tg(sox10:GFP) larvae
(D) demonstrate increased numbers of both dorsally (white brackets) and
ventrally (red brackets) positioned sox10:GFP-positive OPCs as compared with
wild-type; Tg(sox10:GFP) larvae (C) at 4 dpf. (E,F)nf1a–/–; nf1b–/–; Tg(sox10:GFP)
larvae (F) show an increased number of sox10:GFP-positive Schwann cells
associated with the peripheral lateral line nerve (PLLn; white brackets) as
compared with wild-type; Tg(sox10:GFP) larvae (E) at 4 dpf. (G,H)Neuronal
numbers (olig2:GFP- [green], HuC/D- [magenta] positive) do not increase in
concert with OPCs (olig2:GF- [green], Sox10- [red] positive; arrowheads) in
transverse sections through the spinal cord of nf1a–/–; nf1b–/–; Tg(olig2:GFP)
larvae (H) as compared to wild-type; Tg(olig2:GFP) larvae (G) at 4 dpf.
(I,J)Increased numbers of PLLn Schwann cells (sox10:GFP- [green], Sox10- [red]
positive) are appreciated in transverse sections of nf1a–/–; nf1b–/–; Tg(sox10:GFP)
larvae (J) as compared with wild-type; Tg(sox10:GFP) (I) larvae at 4 dpf.
(K,L)Quantification of neurons (olig2:GFP-, HuC/D-positive cells) (K) and OPCs
(olig2:GFP-, Sox10-positive cells) (L) from transverse sections through the spinal
cord of wild-type; Tg(olig2:GFP) and nf1a–/–; nf1b–/–; Tg(olig2:GFP) larvae at 4 dpf.
Values indicate mean + s.e.m. per section (n30 from five each of wild-type and
nf1a–/–; nf1b–/– larvae). (M)Quantification of sox10:GFP-positive Schwann cells in
the PLLn of wild-type; Tg(sox10:GFP) and nf1a–/–; nf1b–/–; Tg(sox10:GFP) larvae at
4 dpf. Values indicate mean + s.e.m. per hemisegment (n5 each for wild-type
and nf1a–/–; nf1b–/– larvae). ***P<0.001. Scale bars: 20m.
dmm.biologists.org
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OPC hyperplasia in nf1a–/–; nf1b–/– larvae results from increased
proliferation
In nf1a–/–; nf1b–/– larvae, OPC numbers were increased relative to
control animals at 4 dpf, but not at 2 dpf, suggesting that nf1-null
OPCs might proliferate faster during this time period. We assessed
OPC proliferation by labeling larvae with BrdU for 12 hours starting
at 3.5, 4.5 and 5.5 dpf followed by immunohistochemical analysis
of transverse sections through the spinal cord. By 4 dpf and
continuing through 6 dpf, the number of olig2:GFP-positive and
Sox10-positive OPCs in nf1-null larvae was significantly increased
in comparison with wild-type controls (Fig. 3A-H, arrows; Fig. 3I).
Mutant larvae further exhibited significantly increased numbers
of olig2:GFP-, Sox10- and BrdU-positive OPCs at 4 and 5 dpf as
compared with controls, indicating that neurofibromin normally
suppresses the proliferation of OPCs during this period of
development (Fig. 3A-H, arrowheads; Fig. 3J). There was little
detectable BrdU incorporation at 6 dpf in either mutant or control
populations.

RESEARCH ARTICLE

expression of mbp, on the other hand, was indistinguishable
between wild-type and nf1a–/–; nf1b–/– larvae at 5 dpf
(supplementary material Fig. S7). However, mbp expression was
elevated in Schwann cells of the PLLn in nf1a–/–; nf1b–/– larvae
as compared with controls (Fig. 4E,F, arrowheads). These data
are consistent with perturbed oligodendrocyte differentiation in
the CNS as well as in PNS Schwann cells associated with the PLLn
of nf1a–/–; nf1b–/– larvae.
We went on to examine the ultrastructure of myelinated CNS
axons in control and nf1-null larvae by transmission electron
microscopy (TEM). At 8 dpf, oligodendritic myelin sheaths were
tightly wrapped around CNS axons in the ventral spinal cord of
wild-type larvae (Fig. 4G,I). By contrast, nf1a–/–; nf1b–/– axons were
loosely encircled by multiple lamellae rather than by compact
myelin sheaths, indicating that neurofibromin is required for the
normal formation of the concentric layers of oligodendrocyte
membranes that enwrap neuronal axons of the CNS to promote
neural conduction (Fig. 4H,J).

Myelination is aberrant in nf1a–/–; nf1b–/– larvae
We evaluated the ability of nf1a–/–; nf1b–/– OPCs to differentiate
appropriately by examining the gene expression levels of
proteolipid protein 1a (plp1a) and myelin basic protein (mbp),
markers of differentiated oligodendrocytes, in wild-type and
mutant larvae at 5 dpf. In nf1-null larvae, fewer plp1a-positive
cells were detected in the midbrain and hindbrain regions (Fig.
4A,B) as well as along the dorsal and ventral spinal cords (Fig.
4C,D) as compared with controls. Central nervous system (CNS)

Fig. 3. Increased proliferation drives OPC hyperplasia in nf1a–/–; nf1b–/–
larvae. (A-H)Transverse spinal cord sections of wild-type; Tg(olig2:GFP) (A-D)
and nf1a–/–; nf1b–/–; Tg(olig2:GFP) larvae (E-H) labeled with anti-BrdU antibody
(B,F, red) or anti-SOX10 antibody (C,G, magenta) at 4 dpf. Arrows indicate
BrdU-negative, Tg(olig2:GFP)-, Sox10-positive OPCs. Arrowheads indicate
BrdU-positive, Tg(olig2:GFP)-, Sox10-positive OPCs. (I,J)Quantification of total
(I) and BrdU-positive OPCs (J) from transverse spinal cord sections of wildtype; Tg(olig2:GFP) and nf1a–/–; nf1b–/–; Tg(olig2:GFP) larvae at 4, 5 and 6 dpf.
Values indicate mean + s.e.m. per section (n30 from five each of wild-type
and nf1a–/–; nf1b–/– larvae). **P<0.01; ***P<0.001. Scale bars: 20m.
Disease Models & Mechanisms

Fig. 4. nf1a–/–; nf1b–/– larvae exhibit myelination defects. (A-D)plp1a
expression is decreased in glial cells of the midbrain and hindbrain regions
(A,B, boxes) as well as the dorsal (black bracket) and ventral (white brackets)
spinal cord of nf1a–/–; nf1b–/– larvae (B,D) as compared to wild-type larvae (A,C)
by whole-mount in situ hybridization at 5 dpf. (E,F)mbp expression is elevated
in Schwann cells of the PLLn (arrowheads) of nf1a–/–; nf1b–/– larvae (F) as
compared to wild-type larvae (E) by whole-mount in situ hybridization at 5
dpf. (G-J)Transverse sections through the ventral spinal cord nf1a–/–; nf1b–/–
larvae (H, boxed region magnified in J) demonstrate defects in formation of
compact myelin sheaths as compared with wild-type larvae (G, boxed region
magnified in I) at 8 dpf. Scale bars: 100m (A-F) and 0.5m (G-J).
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Loss of nf1a and nf1b causes upregulation of Ras signaling in the
spinal cord
Given the well-described role of neurofibromin as a negative
regulator of Ras, we hypothesized that nf1 loss in our mutants would
lead to activation of downstream effector pathways. Western blot
analysis of whole larvae extracts revealed an upregulation of
phosphorylated ERK1 and ERK2 (pERK1/2) in nf1a–/–; nf1b–/–
larvae at 3 dpf, whereas levels in nf1a–/–; nf1b+/+ and nf1a+/+; nf1b–/–
larvae remained unchanged (Fig. 5A). These data are consistent
with the absence of functioning neurofibromin protein in nf1a–/–;
nf1b–/– larvae and support functional redundancy between nf1a
and nf1b. We next assessed the activation of Ras effector pathways
in the spinal cords of wild-type, nf1a+/–; nf1b–/–, nf1a–/–; nf1b+/–
and nf1a–/–; nf1b–/– animals by immunohistochemical analysis of
transverse larval sections. Antibodies directed against HuC/D,
pERK1/2, and phosphorylated S6 (pS6) were used to label neurons
and assess activation of ERK and mTOR signaling pathways,
respectively (Fig. 5B-Q). Although pERK1/2 staining was only
minimally observed in a few neurons and portions of spinal cord
white matter at 4 dpf in wild-type larvae (Fig. 5B,N), a striking
upregulation of pERK1/2 was detected in nf1a–/–; nf1b–/– larvae
(Fig. 5E,Q). Increased ERK signaling was also noted at 3 dpf in spinal
cord neurons and white matter of nf1a–/–; nf1b–/– larvae, but was
absent at 2 dpf (supplementary material Fig. S8). Although pS6
signaling was evident in multiple spinal cord neurons, we observed
no differences in these cells between wild-type and nf1 mutant
animals at 2, 3 or 4 dpf (supplementary material Fig. S8Ae-Ah,BeBh; Fig. 5F-I). These data suggest that activation of mTOR signaling
(as assessed by S6 phosphorylation) is not altered, at least in the
spinal cord following nf1 loss.
nf1 and p53 cooperate to accelerate zebrafish tumorigenesis in
vivo
Mammalian NF1 has been shown to be a potent tumor suppressor;
however, we did not identify any tumors over 18 months of
observation in adult zebrafish homozygous for either mutant nf1
allele alone (nf1a–/–; nf1b+/+ or nf1a+/+; nf1b–/–) or in combination
with heterozygous loss of the remaining allele (nf1a+/–; nf1b–/– or
nf1a–/–; nf1b+/–). Loss of p53 has been shown to cooperate with
NF1 (Cichowski et al., 1999; Vogel et al., 1999) as well as other
mutations that activate Ras signaling (Eliyahu et al., 1984; Parada
et al., 1984; Kemp et al., 1994; Tanaka et al., 1994; Hundley et al.,
1997) in mammalian tumorigenesis, so we next bred p53 mutant
zebrafish into an nf1-mutant background to generate nf1a+/–;
nf1b–/–; p53e7/e7 fish. These animals were incrossed to derive
nf1a+/+; nf1b–/–; p53e7/e7 and nf1a+/–; nf1b–/–; p53e7/e7 fish, which
were subsequently monitored carefully for tumorigenesis. At 31
weeks post fertilization (wpf ), nf1a+/–; nf1b–/–; p53e7/e7 fish began
to develop tumors with high penetrance although only one nf1a+/+;
nf1b–/–; p53e7/e7 fish developed a tumor at 44 wpf (Fig. 6A). At 45
wpf, tumor penetrance was higher in nf1a+/–; nf1b–/–; p53e7/e7 fish
(24/39; 62%) than in nf1a+/+; nf1b–/–; p53e7/e7 fish (1/14; 7%). We
have previously reported that p53e7/e7 fish with wild-type nf1 alleles
develop MPNSTs. These tumors did not begin to develop until 41
weeks of age, which was similar to the results with nf1a+/+; nf1b–/–;
p53e7/e7 animals (Fig. 6A). Furthermore, the penetrance of tumors
in p53-null animals was only 28% by 66 wpf (Berghmans et al.,
2005). Thus, the combined loss of p53 and 3 of 4 nf1 alleles in
886

Fig. 5. nf1a/nf1b mutants exhibit upregulation of pERK1/2. (A)Western
blot analysis for pERK1/2 in protein lysates prepared from wild-type, nf1a–/–;
nf1b+/+, nf1a+/+; nf1b–/– and nf1a–/–; nf1b–/– larvae (100g) reveals increased
pERK1/2 levels in nf1a–/–; nf1b–/– larvae as compared with wild-type, nf1a–/–;
nf1b+/+ and nf1a+/+; nf1b–/– larvae at 3 dpf. Equal loading was confirmed by
stripping the membrane and reprobing for total ERK1/2. (B-Q)Transverse
spinal cord sections of wild-type (B,F,J,N), nf1a+/–; nf1b–/– (C,G,K,O), nf1a–/–;
nf1b+/– (D,H,L,P) and nf1a–/–; nf1b–/– (E,I,M,Q) larvae labeled with anti-pERK1/2
antibody (B-E, green), anti-pS6 antibody (F-I, red), or anti-HuC/D antibody (J-M,
magenta) demonstrate marked upregulation of pERK1/2 in nf1a–/–; nf1b–/–
larvae and intermediate levels of pERK1/2 in larvae harboring a single
functioning nf1 allele as compared with wild-type larvae at 4 dpf (n5 each for
wild-type and mutant larvae). Scale bars: 40m.

zebrafish markedly accelerates the onset and increases the
penetrance of tumors as compared with the loss of p53 alone or
the concomitant loss of p53 and both alleles of nf1b, but with intact
nf1a.
Tumors in nf1a+/–; nf1b–/–; p53e7/e7 fish were observed in the
brain (n2), eye (n8), gill (n1), abdomen (n8) and trunk (n5).
Brain tumors developed very early (31 and 33 wpf) (Fig. 6A, arrows)
and demonstrated features of diffuse high-grade gliomas, whereas
all other tumor types were most consistent with MPNSTs (Fig. 6BG). Histopathologically, the brain tumors were highly cellular and
composed of ovoid to rounded cells with marked nuclear
pleomorphism and diffuse single cell infiltration of parenchyma,
including pre-existing neurons (Fig. 7A-F). Occasional mitoses were
dmm.biologists.org
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Fig. 6. nf1a/nf1b mutants demonstrate increased susceptibility to
tumorigenesis in a p53 mutant background. (A)Kaplan-Meier tumor-free
survival analysis for nf1a+/–; nf1b–/–; p53e7/e7 (n39) animals demonstrates
significantly decreased survival as compared with nf1a+/+; nf1b–/–; p53e7/e7
(n14) animals (P<0.001). Arrows indicate ages at which animals were
identified with brain tumors demonstrating features of diffuse high-grade
gliomas. (B,C)31-week-old nf1a+/–; nf1b–/–; p53e7/e7 animal with a high-grade
glioma (B, arrowhead) and 32-week-old nf1a+/–; nf1b–/–; p53e7/e7 animal with a
malignant peripheral nerve sheath tumor (MPNST) (C, arrowhead). (D-G)H&E
staining of sagittal sections through the high-grade optic glioma (D, boxed
area magnified in F) or MPNST (E, boxed area magnified in G). Scale bars:
200m (D,E) and 50m (F,G).

identified, but no necrosis or vascular proliferation was detected
(Fig. 7G-I). Assessment of tumor lineage by immunohistochemical
analysis showed that approximately 80% of tumor cells stained
positive for the oligodendroglial marker Sox10, with little staining
in matched wild-type tissue (Fig. 7J-L). The presence of a Sox10negative tumor cell subpopulation is consistent with the level of
heterogeneity for oligodendroglial transcription factors, such as
Sox10 and Olig2, and is characteristic of astrocytic or mixed gliomas
as compared with pure oligodendroglial class tumors (Fig. 7K,
arrowhead) (Ligon et al., 2004; Bannykh et al., 2006). Staining for
the astrocytic marker Gfap (Fig. 7M-O) highlighted a subpopulation
of cells within the tumor with coarse, irregular cytoplasmic
Disease Models & Mechanisms
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Fig. 7. Tumors from nf1a+/–; nf1b–/–; p53e7/e7 animals express glial markers.
(A-F)H&E staining of sagittal sections through p53e7/e7 brain tissue (A,D) or
brain tumors in nf1a+/–; nf1b–/–; p53e7/e7 animals at 31 (B,E) and 33 (C,F) wpf
(cb, cerebellum; v, ventricle). The arrowhead in E shows infiltration of a single
cell through the parenchyma and around normal neurons.
(G-U)Immunohistochemical analyses for phosphorylated histone H3 (G-I,
pH3), SRY-box 10 (J-L, Sox10), glial fibrillary acidic protein (M-O, Gfap), HuC/D
(P-R, Hu) and synaptophysin (S-U, Sypa) on sagittal sections through p53e7/e7
brain tissue (G,J,M,P,S) or brain tumors in nf1a+/–; nf1b–/–; p53e7/e7 animals at 31
(H,K,N,Q,T) and 33 (I,L,O,R,U) wpf demonstrate occasional mitoses in tumor
tissue (H,I) with most tumor cells staining positive for the oligodendroglial
marker Sox10 (K,L), a Sox10-negative subpopulation (K, arrowhead), an
astrocytic component (N, arrowheads and O) and the absence of mature
neuronal markers HuC/D (Q,R) or synaptophysin (T,U). Scale bars: 450m (A-C)
and 20m (D-U).

processes also consistent with the presence of an astrocytic lineage
component (Fig. 7N, arrowheads). Tumor cells did not express the
mature neuronal markers HuC/D or synaptophysin (Sypa),
consistent with their glial origin (Fig. 7P-U).
887

RESEARCH ARTICLE

Zebrafish model of neurofibromatosis type 1

Disease Models & Mechanisms DMM

Immunohistochemical analysis for pERK1/2 and pS6 to assess
activation of ERK and mTOR signaling pathways, respectively
(supplementary material Fig. S9A-F) revealed increased pERK1/2
staining in the more malignant of these two brain tumors, with
normal amounts of pS6 (supplementary material Fig. S9C,D). The
more hyperplastic brain tumor showed increased pERK1/2 and pS6
staining (supplementary material Fig. S9E,F). These data
demonstrate that some, but not all, brain tumors in nf1a+/–; nf1b–/–;
p53e7/e7 animals demonstrate hyperactivation of ERK and mTOR
pathways, consistent with mouse and human NF1-derived MPNSTs
and gliomas (Dasgupta et al., 2005; Zhu et al., 2005b). Collectively,
these findings suggest that the tumors were high-grade gliomas
most closely resembling human anaplastic astrocytoma or
anaplastic oligoastrocytoma WHO grade III. Furthermore,
MPNSTs (Fig. 6C,E,G) exhibited spindle-shaped tumor cells and
extensive necrosis consistent with this tumor type (Ducatman et
al., 1986; Wanebo et al., 1993; Hirose et al., 1998). Taken together,
we conclude that nf1a and nf1b mutations cooperate with p53 loss
to generate high-grade gliomas and MPNSTs.
nf1a–/–; nf1b–/– larvae show motor and learning deficits
Deficits in motor coordination and cognition, including learning
and memory, are characteristic of NF1 patients and animal models.
To examine motor behavior and cognition in nf1a–/–; nf1b–/– larvae,
we performed kinematic analysis of the short-latency C-start
(SLC), a highly stereotyped yet modifiable acoustic startle reflex in
the zebrafish (Burgess and Granato, 2007a; Wolman et al., 2011).
Unlike their siblings, nf1a–/–; nf1b–/– larvae showed a deficit in
short-term SLC habituation when presented with repetitive
acoustic stimulation (supplementary material Fig. S10A).
Furthermore, nf1a–/–; nf1b–/– larvae performed kinematically
weaker SLC responses, as indicated by decreased head turning
angle, maximum angular velocity and distance traveled following
delivery of an acoustic stimulus (supplementary material Fig. S10BD). Taken together, these data support the hypothesis that nf1a and
nf1b function redundantly during zebrafish development and that
only one of the four wild-type nf1 alleles is required for
phenotypically normal embryonic development, motor behavior
and cognition.
nf1 mutants exhibit melanophore defects
Notably, nf1 null larvae displayed aberrant lateral stripe
pigmentation as compared with wild-type controls at 6 dpf (Fig.
8A-D). This phenotype was first appreciable at 4 dpf and was
manifested as a disruption in the uniform pattern of melanophores
arranged along the lateral stripes (Fig. 8B,D, brackets). To further
investigate this phenotype, we quantified melanophore numbers
along the lateral stripes of 3 and 6 dpf wild-type and nf1a–/–; nf1b–/–
larvae. No significant differences in the number of melanophores
comprising the 3 dpf lateral stripes were appreciable in any
combination of mutant nf1 alleles as compared with sibling wildtype controls (supplementary material Fig. S11). However, at 6 dpf,
nf1a–/–; nf1b–/– larvae exhibited a significant reduction in the
number of lateral stripe melanophores (Fig. 8E). Less severe, but
still significant, decreases were also noted in larvae carrying two
or three mutant nf1 alleles (Fig. 8E). No difference in the number
of apoptotic cells between wild-type and mutant larvae was
discernible at 3 dpf (68.1±11 cells/larva, n12 wild-type versus
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Fig. 8. nf1 mutants display decreased lateral stripe melanophores.
(A-D)Lateral stripe melanophores of wild-type (A,B) larvae demonstrate a
normal uniform pattern that is absent in nf1a–/–; nf1b–/– larvae (C,D) at 6 dpf.
The brackets in D highlight regions where melanophores are absent.
(E)Quantification of lateral stripe melanophores from wild-type (n26),
nf1a+/–; nf1b–/– (n30), nf1a–/–; nf1b+/+ (n14), nf1a–/–; nf1b+/– (n26) and nf1a–/–;
nf1b–/– (n12) larvae at 6 dpf. Each point represents the number of lateral
stripe melanophores in an individual embryo and red lines indicate mean
values. *P<0.05, **P<0.01. Scale bars: 0.5 mm (A,C) and 150m (B,D).

63.8±8.5, n12 mutants; P0.27) (supplementary material Fig.
S12A-F). Serial observation of melanophore development in
individual nf1a–/–; nf1b–/– and wild-type larvae revealed a defect
of migration or differentiation of regeneration and metamorphic
lineage melanophores. At 3 dpf, a time point at which embryonic
melanophore development is complete (Hultman et al., 2009), no
difference in melanophore number along the lateral stripe was
observed (supplementary material Fig. S13A,B,G), indicating that
the melanophores develop normally in nf1 mutants. To assess the
regeneration and metamorphic lineage of melanophores, we
suppressed melanin synthesis after 3 dpf by treatment with Nphenylthiourea (PTU) (Hultman and Johnson, 2010), which allowed
us to identify newly formed melanophores by their melaninnegative and pale appearance (supplementary material Fig. S13C,D,
red arrows). Removal of PTU at 5 dpf restored melanin synthesis
and regeneration and metamorphic melanophores appeared
dmm.biologists.org
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melanin-positive by 6 dpf (supplementary material Fig. S13E,F,
black arrows). The abnormal appearance of the lateral stripes in
mutant larvae can be attributed to defects in patterning of
regeneration and metamorphic melanophores (supplementary
material Fig. S13F,G, brackets), suggesting abnormal migration or
differentiation of this lineage. Head melanophore numbers at 6 dpf
were not significantly changed in nf1 mutant larvae and sibling
controls (supplementary material Fig. S14). Collectively, these data
demonstrate a specific defect in lateral stripe melanophore numbers
following nf1 allele loss, most prominent in the setting of biallelic
nf1a/nf1b loss. Each nf1a–/–; nf1b–/– larvae showed a unique
pattern of lateral stripe melanophore loss, suggesting a stochastic
defect in melanophore differentiation from neural crest,
proliferation, migration or survival, rather than a defect specific to
any particular somite of the developing embryo and larvae.
DISCUSSION
NF1 is a common tumor-predisposing, autosomal dominant genetic
disorder characterized by café-au-lait macules and cutaneous
neurofibromas. In addition to these pigmentation defects and
tumors of the peripheral nervous system (PNS), NF1 patients
demonstrate highly diversified clinical features with multiple tissue
types affected. Prominent lesions include optic pathway gliomas,
Lisch nodules, skeletal dysplasia, cardiovascular abnormalities,
learning defects and various cancers such as leukemia and intestinal
tumors (Side et al., 1997; Side et al., 1998; Bahuau et al., 2000;
Andersson et al., 2005; Williams et al., 2009). It remains unclear
how NF1 mutations contribute to the diverse symptoms and tissue
types affected in patients. Because neurofibromin is a very large
protein that is highly conserved evolutionarily, it is likely to have
activities related to functional domains other than those affecting
Ras signaling. For example, in addition to Ras, neurofibromin can
bind to microtubules, syndecan, phospholipids and amyloid
precursor protein (Xu and Gutmann, 1997; Hsueh et al., 2001;
D’Angelo et al., 2006; De Schepper et al., 2006). Intriguingly, recent
studies indicate that neurofibromin might function as a positive
regulator of adenylyl cyclase (Guo et al., 2000; Tong et al., 2002;
Dasgupta et al., 2003). This function of neurofibromin modulates
neuronal differentiation (Hegedus et al., 2007), suggesting the
possibility that cognitive defects in NF1 patients might be related
to defects in cAMP signaling rather than activated Ras.
Furthermore, the tremendous clinical variability in the phenotypic
spectrum seen among families with the same molecular NF1 lesion
posits the role of unlinked modifier loci in regulating the
expressivity of disease characteristics (Easton et al., 1993; Sabbagh
et al., 2009). Nevertheless, the identification of specific modifier
genes and the relative contributions of Ras signaling versus other
neurofibromin-regulated pathways for specific phenotypes have yet
to be fully elucidated. The zebrafish model that we have developed
offers an attractive tool for furthering this analysis because it is
amenable to small molecule screens, genetic modifier screens and
genetic rescue experiments.
A hallmark feature of human NF1 is the presence of pigmentation
defects known as café-au-lait spots. Little is known about the
underlying mechanisms responsible for this abnormality, and
pigmentation abnormalities in other animal models of NF1 have
not been described. In this regard, it is of interest that zebrafish
lacking neurofibromin exhibit abnormal patterning of the
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melanophores that compose the lateral stripes, a phenotype similar
to that following pharmacologic inhibition of the upstream Ras
effector ErbB (Hultman et al., 2009; Hultman and Johnson, 2010).
This easily observable and quantifiable phenotype offers the
opportunity to probe underlying molecular pathways modulated
by nf1 in melanophores.
Several studies employing murine models have previously shown
a role for neurofibromin in regulating cell numbers of CNS OPCs
and astrocytes as well as PNS Schwann cells and sympathetic
neurons (Brannan et al., 1994; Gutmann et al., 1999; Bennett et al.,
2003; Zhu et al., 2005b; Hegedus et al., 2007; Zheng et al., 2008).
These are consistent with our findings in nf1a/nf1b mutants and
indicative of a strong evolutionary conservation of Nf1 function in
neural development. Our observation of impaired compact myelin
formation and reduced CNS plp1a expression with unperturbed
CNS and increased PNS mbp expression suggests that the
differentiation programs of oligodendrocytes and Schwann cells
respond differently to Nf1 deficiency. Alternatively, the observed
ultrastructural defects in myelinated CNS axons might arise
secondary to neuronal defects. The accessibility of the zebrafish
embryo to mosaic analysis offers the ability to differentiate between
these possibilities. Unlike Nf1-deficient mice, however, nf1a/nf1b
mutant radial glia failed to demonstrate an appreciable increase in
Gfap expression. Instead, we observed a decrease in Blbp expression
and irregularities in patterning of nf1a–/–; nf1b–/– radial glial cells.
This discrepancy might reflect species-specific differences in neural
tissue as opposed to Nf1 function, because it remains unclear
whether zebrafish radial glia-like ependymal cells are functionally
equivalent to mammalian astrocytes.
We have previously characterized cardiovascular defects
resulting from morpholino knockdown of nf1a and nf1b in zebrafish
(Padmanabhan et al., 2009; Lee et al., 2010). These defects were
observed at 48 and 72 hpf and probably resulted from impairment
of both maternal and zygotic gene expression. In our stable
compound mutants, we observed partially penetrant insufficiency
of the atrioventricular valve at 3 dpf along with significant edema
and impaired blood circulation associated with irregular heart rates
beginning at 5-6 dpf (data not shown). However, we could not
determine whether these effects were primary or secondary. It is
possible that impaired cardiac function is the cause of death of these
larvae. The absence of earlier cardiovascular phenotypes is most
probably due to the activity of maternal transcripts (Abrams and
Mullins, 2009); confirmation of this interpretation awaits the
creation of a maternal zygotic mutation.
Ubiquitous and conditional Nf1 knockout mice have been
generated to investigate the role of neurofibromin in development
and tumorigenesis (Cichowski and Jacks, 2001; Le and Parada,
2007). Conditional loss of Nf1 with p53 deficiency in mice results
in the development of grade III and IV astrocytomas with full
penetrance (Zhu et al., 2005a), indicating that Nf1 mutations are
associated not only with low-grade but also high-grade
astrocytoma. Indeed, two independent studies have demonstrated
that NF1 mutations are found in about 15-23% of human
glioblastoma multiformes (GBMs) (Parsons et al., 2008; The
Cancer Genome Atlas Research Network, 2008). Interestingly, we
also observed gliomas in zebrafish lacking nf1 and p53. Likewise,
MPNSTs are observed in both mouse and zebrafish models. Thus,
the relative advantages of murine and zebrafish systems can be
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leveraged for future studies aimed at developing therapeutics for
these lethal complications of NF1.
In summary, we have developed and characterized zebrafish lines
containing specific targeted mutations in nf1a and nf1b. Compound
deficiency of nf1a and nf1b results in lethality and predisposes to
tumor formation. These studies provide a powerful new tool for
analysis of neurofibromin function and for the development of
therapies for a common human disorder.
METHODS
Zebrafish lines
The nf1a⌬5, nf1a⌬8, nf1b+10 and nf1b⌬55 mutant alleles were
generated by application of modularly assembled ZFNs. The
nf1aL1247X mutant allele was generated by TILLING. Our nf1
mutant alleles were crossed into various transgenic lines, including
Tg(gfap:GFP) (Lam et al., 2009), Tg(sox10:GFP) (Thermes et al.,
2002; Carney et al., 2006) and Tg(olig2:GFP) (Shin et al., 2003), as
well as the p53e7/e7 mutant line (Berghmans et al., 2005). Zebrafish
were maintained under standard conditions as previously described
(Westerfield, 2000). All experiments involving animals were
approved by the Institutional Animal Care and Use Committees
of Harvard University and the University of Pennsylvania.
TILLING with screening by CEL-I method
Individual samples from a preconstructed ‘live library’ of pooled
genomic DNA from ENU-mutagenized F1 animals were used as a
template for PCR with the following PCR primer pairs:
nf1a_outer_F, 5⬘-TGGCAAATAAATGCTGACAGA-3⬘ and
nf1a_inner_F, 5⬘-HEX-TTTTTATATCTCATGTTTAGCTCACAA-3⬘; nf1a_outer_R, 5⬘-AAGTCTTAAATGGCCTGAGTGG-3⬘
and nf1a_inner_R, 5⬘-6FAM-AAATGGCCTGAGTGGTAATAAA3⬘. A nested PCR was performed first using the outer primer pair
with the following PCR conditions: 94°C for 2 minutes; 30 cycles
of 94°C for 30 seconds, 60°C for 40 seconds and 72°C for 1 minute;
and 72°C for 5 minutes. Amplification was then performed using
the inner primer pair with the following PCR conditions: 94°C for
2 minutes; 25 cycles of 94°C for 30 seconds, 60°C for 40 seconds
and 72°C for 1 minute; and 72°C for 5 minutes. PCR products were
denatured, allowed to re-anneal, subjected to CEL-I digestion and
separated by acrylamide electrophoresis using a LI-COR DNA
analyzer. Upon identification of a genomic DNA sample harboring
a mutation in the analyzed region, the individual animals
comprising that genomic DNA pool were rescreened to identify
the appropriate F1 animal harboring the lesion of interest. This F1
animal was then outcrossed to wild-type fish and progeny were
selected on the basis of the presence of the desired mutation. A
genotyping strategy was developed to identify animals harboring
the nonsense allele isolated by our TILLING strategy using the
following PCR primers: nf1a_stop_PstI_F, 5⬘-CTCTCTTCGACTCTCGCCATCTGCTGTATCAGCTGC-3⬘ and nf1a_stop_R,
5⬘-GAAGCAGAAGGTCATAATCTTGCTGGCTAGGC-3⬘. PCR
conditions were 95°C for 2 minutes; 32 cycles of 94°C for 30
seconds, 62°C for 30 seconds and 72°C for 30 seconds; and 72°C
for 5 minutes. This generates a 134 bp PCR product. The wildtype allele is resistant to PCR digestion by PstI, but the mutant
allele is not.
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Modular assembly of ZFNs
The desired three finger zinc finger proteins (ZFPs) were
constructed by a splice overlap extension PCR strategy, with
individual finger modules amplified from a archive of ZFPs with
defined DNA-binding specificities (Zhu et al., 2011). Three
individual fingers (F1, F2 and F3) were amplified using primers
specific to their desired backbone position, followed by an
overlapping PCR step to place them together into a single ZFP
fragment which was cloned, sequence verified and subsequently
subcloned in frame with a FokI nuclease variant in a pCS2
expression plasmid. The primers for the three backbone positions
were
as
follows:
F1
forward,
5⬘-GCGATGGGTACCCGCCCATATGCTTGC-3⬘ and F1 reverse, 5⬘CACTGGAAGGGCTTCTGGCCTGTGTGAATCCGGATGTG3⬘; F2 forward, 5⬘-CATCCGGATTCACACAGGCCAGAAGCCCTTCCAGTGTCGCATCTGC-3⬘ and F2 reverse, 5⬘ATGTCGCATGCAAAAGGCTTCTCGCCTGTGTGGGTGCGG
ATGTG-3⬘; F3 forward, 5⬘-CGAGAAGCCTTTTGCATGCGACA3⬘ and F3 reverse, 5⬘-GCGTAGGATCCACCTGTGTGGATCTTGGTGTG-3⬘. The PCR conditions for amplifying F1 were 98°C for
2 minutes and 15 cycles of 94°C for 30 seconds, 68°C for 30 seconds
and 72°C for 20 seconds. The PCR conditions for F2 and F3 were
98°C for 2 minutes and 20 cycles of 94°C for 30 seconds, 57°C for
30 seconds and 72°C for 30 seconds. The three individual gelpurified PCR products for positions F1, F2 and F3 were combined
(15 ng of each) in a PCR using Advantage 2 HiFi polymerase
(Clontech) and subjected to the thermal cycling of 94°C for 2
minutes and five cycles of 94°C for 30 seconds, 55°C for 30 seconds
and 72°C for 30 seconds. Following this cycling program, F1 forward
and F3 reverse primers were added to the reaction and thermal
cycling was continued as follows: 25 cycles of 94°C for 15 seconds
and 68°C for 30 seconds. This PCR product of approximately 300
bp was gel-purified, cloned, sequence verified and subcloned in
frame with the DD/RR or EL/KK FokI variants (Miller et al., 2007;
Szczepek et al., 2007) with and without the 3⬘-UTR of nanos1
(Koprunner et al., 2001).
ZFN mRNA injections and genotyping assays
We utilized protocols similar to those recently described (Zhu et
al., 2011). pCS2-based expression plasmids containing our
constructed ZFNs were linearized downstream of the SV40
polyadenylation signal and used as templates for in vitro
transcription of ZFN mRNAs (Ambion). One-cell fertilized
zebrafish embryos were injected with varying amounts of DD/RR
or EL/KK FokI variant mRNAs. Site-specific ZFN function was
verified by a genotyping strategy wherein introduction of mutagenic
lesions at the target site leads to loss of a unique endogenous
restriction site. This same strategy was later used to genotype F1
animals. For nf1a and nf1b, PCR was performed using the following
primer pairs and PCR conditions: nf1a F genotyping primer, 5⬘GGTGTGTATGTAAATGGGCTCAATG-3⬘; nf1a R genotyping
primer, 5⬘-TACAGTTTCCATAAAACCTGACATTTC-3⬘; nf1b F
genotyping primer, 5⬘-TGCTACCTGCCGGCAGGCTCAG-3⬘;
and nf1b R genotyping primer, 5⬘-ACCTGTGACCATCATGTTACTGACA-3⬘. PCR conditions for nf1a were 94°C for 2
minutes; 35 cycles of 94°C for 30 seconds, 54.8°C for 30 seconds
and 72°C for 40 seconds; and 72°C for 5 minutes. PCR conditions
for nf1b were 94°C for 2 minutes; 35 cycles of 94°C for 30 seconds,
dmm.biologists.org
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62°C for 30 seconds and 72°C for 40 seconds; and 72°C for 5
minutes. For both nf1a and nf1b, a 223-bp PCR product was
generated. Mutant alleles were resistant to subsequent digestion
with BspCNI or DdeI (nf1a) and BslI or EcoNI (nf1b), whereas the
wild-type alleles were completely digested. The molecular identities
of the various mutant alleles were determined by cloning and
sequencing the restriction enzyme-resistant PCR products from
individual embryos derived from outcrosses of F1 animals to wildtype fish.
Larval genotyping
A modified fin clip genotyping strategy was utilized to identify larval
genotypes prior to sacrifice. Briefly, 2-dpf larvae were anesthetized
with tricaine and stereomicroscopic amputation was performed on
the caudal fin with an angled dissecting knife (Fine Science Tools,
10056-12). Genomic DNA from fin-clipped tissue samples was
prepared by collecting specimens in 1.5 l of the surrounding
medium and dispensing into PCR tubes containing 7.5 l of 60
mM NaOH, which were incubated at 95°C for 20 minutes followed
by 4°C for 5 minutes with the subsequent addition of 1 l of 1 M
Tris-HCl pH 8. Genotyping for nf1a or nf1b was performed as
described with an increase in PCR cycle number to 40. Genomic
DNA prepared by this strategy was sufficient for a single genotyping
reaction. Thus, parental crosses were selected to ensure all progeny
were homozygous for the non-genotyped nf1 allele (e.g. nf1a+/–;
nf1b–/– incross). This was verified by genotyping the homozygous
mutant allele in sibling clutchmates.
Whole-mount in situ hybridization and TUNEL staining,
immunohistochemistry and BrdU labeling
Antisense RNA probes were generated for plp1a (Park et al., 2002)
and mbp (Lyons et al., 2005) using a digoxigenin RNA labeling kit
(Roche). A previously published protocol (Thisse and Thisse, 2008)
was followed with minor modifications. Terminal deoxynucleotidyl
transferase dUTP nick-end labeling (TUNEL) staining of larvae was
performed using the ApopTag Peroxidase In Situ Apoptosis Detection
Kit (EMD Millipore) with minor modifications. Larvae were
subsequently blocked in 2% blocking reagent (Roche) for 4 hours at
room temperature and incubated overnight in anti-digoxigenin-POD
antibody (Roche; 1:500) at 4°C. TUNEL-positive cells were detected
using the TSA fluorescein system (PerkinElmer). Apoptotic cells were
quantified by counting TUNEL-positive cells between somites 6 and
15. For immunohistochemical analysis of zebrafish larvae, we used
mouse anti-BrdU (Developmental Studies Hybridoma Bank G3G4;
1:1000), mouse anti-HuC/D (Invitrogen A-21271; 1:100), mouse antipERK1/2 (Sigma; 1:200), mouse anti-Zrf1 (Zebrafish International
Resource Center; 1:1000), rabbit anti-BLBP (Millipore AB9558;
1:1000), rabbit anti-pS6 (Cell Signaling 2211; 1:200), and rabbit antiSOX10 (Park et al., 2005) (a generous gift from Bruce Appel,
University of Colorado, Denver, CO; 1:5000) as primary antibodies.
For fluorescent detection of antibody labeling, we used anti-mouse
and anti-rabbit IgG antibodies conjugated with Alexa Fluor 488, 568
and 647 (Invitrogen; 1:200). Immunohistochemistry of adult zebrafish
tumor samples was performed according to a previously published
protocol (Ligon et al., 2004). Primary antibodies included antipERK1/2 (Cell Signaling 4370; 1:200), anti-pS6 (Cell Signaling 2211;
1:50), anti-phosphorylated histone H3 (Cell Signaling 9706; 1:100),
rabbit anti-SOX10 (Park et al., 2005) (1:3000), mouse anti-GFAP
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(Sigma G3893; 1:10,000), anti-HuC/D (Invitrogen A-21271; 1:200)
and anti-synaptophys (Millipore MAB5258; 1:1000). Antibody
binding was detected using a diaminobenzidine-peroxidase
visualization system (EnVision+, Dako). Mayer’s hematoxylin was
used for counterstaining. For BrdU labeling, embryos were incubated
in BrdU solution (10 mM BrdU in 2% DMSO) for 12 hours. After
BrdU incubation, embryos were fixed with 4% paraformaldehyde and
embedded in 1.5% agarose. Sections from embedded frozen
specimens were immersed in 2 M HCl for 15 minutes and processed
for immunohistochemistry. Paraffin sectioning followed by
hematoxylin and eosin (H&E) staining was performed at the DanaFarber/Harvard Cancer Center Research Pathology Core.
Behavioral analysis
Startle behavioral experiments were performed on 5-dpf larvae raised
as previously described (Burgess and Granato, 2007b). Larvae with
underinflated swim bladders were excluded from behavioral testing.
Acoustic startle responses were elicited and measured as previously
described (Burgess and Granato, 2007a; Wolman et al., 2011), such
that larvae could be tracked and analyzed individually. All startle
stimuli were 1000 Hz waveforms of 3 milliseconds duration at an
intensity of approximately 150 m/second2. Stimulus intensity was
calculated by measuring the displacement of the testing arena due
to vibration. To evaluate short latency C-start (SLC) behavior, images
were recorded 30 milliseconds prior to and 90 milliseconds following
the delivery of the 3 millisecond acoustic stimulus. To examine
acoustic startle larval motor behaviors, we captured video recordings
using a MotionPro high-speed camera (Redlake) at 1000 frames per
second with 512⫻512 pixel resolution using a 50 mm macro lens.
Behavioral analyses were carried out with the FLOTE software
package (Burgess and Granato, 2007b; Burgess and Granato, 2007a).
Startle short-term habituation was performed and analyzed as
previously described (Wolman et al., 2011). Larvae were genotyped
following behavioral testing.
Western blotting
Protein lysates were prepared from 3-dpf wild-type, nf1a–/–; nf1b+/+,
nf1a+/+; nf1b–/– and nf1a–/–; nf1b–/– larvae. Briefly, groups of 1020 larvae with identical genotype were anesthetized with tricaine,
deyolked in a solution of ice-cold PBS with 0.1% Tween-20 (PBST),
transferred to a pre-chilled microcentrifuge tube containing 5 l
of lysis buffer (150 mM NaCl, 50 mM Tris-HCl pH 8, 5 mM EDTA,
1 mM PMSF, 1% Igepal CA 630, 0.5% sodium deoxycholate, 0.1%
SDS and 1⫻ Halt protease inhibitor cocktail (Thermo Fisher
Scientific) per larva, sonicated using a Bioruptor (Diagenode) and
cleared by centrifugation. Larval (100 g) and 293T (25 g) protein
lysates were separated by gel electrophoresis, transferred to PVDF
membranes and probed overnight at 4°C with the following primary
antibodies: anti-neurofibromin (Abcam ab17963; 1:1000), anti-tubulin (Sigma T6074; 1:1000), anti-pERK1/2 (Cell Signaling 4377;
1:1000), and anti-ERK1/2 (Cell Signaling 9102; 1:1000). Primary
antibody binding was visualized on X-ray film using anti-mouseHRP (Cell Signaling 7076; 1:10,000) or anti-rabbit-HRP (Cell
Signaling 7074; 1:10,000) secondary antibodies along with
LumiGLO (Cell Signaling) or SuperSignal West Femto (Thermo
Fisher Scientific) chemiluminescent substrates. Each Western blot
was performed in three independent replicates with a representative
image of one presented.
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Quantification of lateral line and head melanophores
Lateral stripe melanophores, including those observed along the
horizontal myoseptum, were counted by a blinded observer in live
progeny from nf1a+/–; nf1b+/– incrosses at 3 and 6 dpf. Each discrete
melanized region was counted as a single melanophore. Following
6-dpf lateral stripe melanophore quantitation, larvae were
immersed in E3 medium containing 5 mg/ml epinephrine (Sigma
E4375) for 10 minutes to induce contraction of melanosomes
around cell bodies and allow evaluation of head melanophore
numbers. Larvae were fixed overnight in 4% paraformaldehyde in
PBS at 4°C, washed twice with PBS for 5 minutes, and melanophores
anterior to somite one across the crown of the head (supplementary
material Fig. S14) were counted. Larvae were subsequently
genotyped for nf1a and nf1b. Data analysis was performed by oneway ANOVA with Dunnett’s post-test (GraphPad InStat 3.1a,
GraphPad Software).
Serial tracking of lateral line melanophores
Lateral stripe melanophores of live progeny from nf1a+/–; nf1b–/– or
wild-type incrosses were individually imaged at 3 dpf followed by
incubation with 0.2 mM N-phenylthiourea (PTU, Sigma) to prevent
melanin synthesis. At 5 dpf, lateral stripe melanophores were again
imaged, after which PTU was washed out. Larvae were reimaged at
6 dpf and subsequently genotyped for nf1a. Images were acquired
using a Nikon SMZ1500 microscope and NIS-Elements F2.20
software with identical settings. Melanophores in a 200-m region,
corresponding to roughly 12 somites at 3 dpf, were counted at 3 and
6 dpf for each larva. Statistical analysis was performed using a onetail, unpaired t-test (GraphPad Prism 5, GraphPad Software).
Intestinal transit assays
Groups of 5-dpf wild-type and nf1a–/–; nf1b–/– larvae were placed
in individual wells of six-well plates containing feeding medium [4
ml E3, 2 ml paramecia culture and 5 l of 2-m yellow-green
microspheres (Polysciences 18338)]. Larvae were incubated at
28.5°C for 1 hour followed by several E3 washes. Individual larvae
were transferred to 24-well plates and visually assessed for the
presence of fluorescent microspheres in the intestinal bulb. Extent
of intestinal transit was observed at 2, 4, 6 and 24 hours. Transit
was considered to be complete when fluorescence was no longer
detectable in the intestinal tract.
Transmission electron microscopy
TEM was carried out at the Harvard Medical School Electron
Microscopy Facility. Briefly, embryos were fixed in 2% formaldehyde
and 2.5% glutaraldehyde, post-fixed with 1% osmium tetroxide and
embedded in epon. Sections were collected in the trunk region of
embryos. Images were captured by a Tecnai G2 Spirit BioTWIN
electron microscope with an AMT 2k CCD camera.
Tumor identification
nf1a⌬8/+; nf1b+10/+10; p53e7/e7 fish were incrossed and progeny were
manually evaluated weekly for 45 weeks. Animals identified as having
tumors were separated and fin-clipped for genotyping purposes.
These samples were subsequently subjected to histological and
immunohistochemical analyses as described above for determination
of tumor type. At the completion of 45 weeks, all tumor-free fish
were genotyped for subsequent statistical analysis.
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TRANSLATIONAL IMPACT
Clinical issue
Neurofibromatosis type 1 (NF1) is one of the most commonly inherited human
genetic disorders. Despite nearly complete penetrance, the clinical expression
of NF1 varies widely, even within families harboring identical mutations at the
NF1 locus. Not surprisingly, few genotype-phenotype relationships have thus
far been reported for NF1, suggesting important contributions from unlinked
modifier genes and/or environmental factors. However, these observations do
not preclude mutations or deletions within the NF1 locus from influencing
pathology. Instead, they highlight the need for better experimental tools to
address this important and clinically relevant observation. Additional models
of NF1 are needed to begin elucidating these mechanisms using scalable
chemical and genetic approaches.

Results
The authors employ zinc finger nucleases and TILLING to isolate null alleles of
the two zebrafish orthologues of human NF1, nf1a and nf1b. They report that
zebrafish lacking nf1a and nf1b exhibit valvular insufficiency, defects in
learning and behavior and early larval lethality. Larvae carrying a single wildtype allele of either nf1a or nf1b are viable and fertile, suggesting functional
redundancy. The authors also observe hyperplasia and aberrant differentiation
in the oligodendrocyte progenitor cells and Schwann cells populating the
nervous systems of nf1-null larvae. This is accompanied by irregularities in the
myelin sheaths surrounding the neuronal axons of the central nervous system.
Human NF1 is a potent tumor-suppressor gene and the authors provide
evidence that zebrafish nf1a and nf1b function similarly: they demonstrate
that Ras is hyperactivated in the spinal cords of nf1-null larvae, and that the
combined loss of nf1 and p53 accelerates tumorigenesis. Finally, the authors
characterize a melanophore defect resulting from nf1 loss that disrupts the
uniform pigmentation pattern observed along the lateral stripes.

Implications and future directions
Using zebrafish to probe the genetic, epistatic and environmental factors
underlying NF1 pathology offers several important advantages over currently
available murine models. The low costs and high fecundity of zebrafish
coupled with their ability to survive for several days as haploid organisms
make them amenable to large-scale genetic screens. Thus, nf1-deficient
zebrafish should greatly facilitate the identification of modifier genes
influencing NF1 pathogenesis. In addition, genetic rescue experiments using
specific NF1 mutations or deletions could clarify the molecular basis of
pathology. The feasibility of high-throughput chemical screening using this
model should provide additional valuable mechanistic insights and identify
lead compounds for future therapeutics. Few treatment options are currently
available for individuals affected with NF1, so advances in this area are
urgently needed. Importantly, this represents the first animal model that
demonstrates pigmentation defects analogous to the pathognomonic café-aulait spots seen in affected individuals. Therefore, this model will provide a
platform for further investigation of one of the most common clinical
pathologies associated with NF1.
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